Skip to main content
OpenTrials
Completed

NCT Number: NCT05289583

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Borderline Personality Disorder Dropout Mental Disorders Personality Disorders Psychotherapy

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Department

Bielefeld, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • three or more criteria for BPD as defined by DSM-5 (Borderline Personality characteristics; BPC)

Exclusion criteria

  • inability to contract and consent,
  • other severe mental disorders (bipolar disorder, acute psychosis),
  • current alcohol,
  • illicit or not prescribed drug use,
  • simultaneous participation in other treatment studies,
  • pregnancy or breastfeeding,
  • an inability to negotiate a non-suicide agreement,
  • ongoing traumatic contact with the perpetrator, and
  • a Body Mass Index < 16.5.

Treatment and study plan

Dialectical behavior therapy

Behavioral

DBT is a cognitive-behavioral treatment program that was developed to treat suicidal Patients with BPD (Linehan, 1993).

Primary outcomes

  1. Rate of Dropout

    Time frame: 8-10 weeks

    premature termination of treatment

Sponsors and collaborators

Lead sponsor

Evangelisches Krankenhaus Bielefeld gGmbH

Other

Registry information

Acronym: DBT_dropout2

Important dates

Study start
2019
Primary completion
2021
Study completion
2022
First posted
Mar 21, 2022
Registry last updated
Apr 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.